Jaguar Health must report a closing bid price of $1 per share for 10 consecutive business days or face delisting from the stock index, according to an Aug. 19 company news release.
“We are pleased to have obtained additional time from Nasdaq to evidence compliance with the bid price requirement,” Jaguar President and CEO Lisa Conte said. “Jaguar is focused on two late-stage clinical events in the next approximately six to 12 months that we expect to be transformational in terms of value creation and recognition for the company as we seek to regain compliance with the rule.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
